Related Experiment Video
Updated: Jul 8, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Microtubule-stabilizing natural products as promising cancer therapeutics
1Alantos Pharmaceuticals, Inc., Cambridge, MA 02139, USA. bmgallagherjr@hotmail.com
Abstract:
Paclitaxel and related taxanes exhibit their anticancer activity by promoting tubulin polymerization and stabilizing microtubules, which results in mitotic G2/M arrest and apoptosis. The clinical success of paclitaxel in treating a wide array of tumor types has led to numerous efforts to identify novel natural products with paclitaxel-like mechanisms of action, but which may overcome some of the liabilities of the taxanes. Although the list of natural products that share the paclitaxel-like mechanism is relatively small, it continues to expand and currently includes a number of structurally distinct classes. Despite the mechanistic similarities between these classes, differences exist which may translate into their differential efficacy in the clinic. The past several years have seen a considerable amount of pre-clinical and clinical progress in developing these novel microtubule-stabilizing natural products as cancer therapeutics. This review focuses primarily on recent advances published since 2002.
Insights
Novel natural products that stabilize microtubules offer new anticancer therapies. These agents, similar to paclitaxel, promote cell cycle arrest and apoptosis, expanding treatment options for various cancers.
Area of Science:
- Pharmacology and Natural Products Chemistry
- Cancer Biology and Therapeutics
Background:
- Paclitaxel and taxanes are successful anticancer drugs that stabilize microtubules, inducing cell cycle arrest and apoptosis.
- The search for novel natural products with similar mechanisms aims to overcome taxane limitations.
- Several structurally distinct classes of natural products share this microtubule-stabilizing mechanism.
Purpose of the Study:
- To review recent advances in natural products that mimic paclitaxel's anticancer mechanism.
- To highlight progress in developing these novel microtubule-stabilizing agents since 2002.
Main Methods:
- Literature review of pre-clinical and clinical studies on natural products with microtubule-stabilizing activity.
- Focus on research published from 2002 onwards.
Main Results:
- The repertoire of natural products with paclitaxel-like mechanisms is expanding.
- These agents, despite mechanistic similarities, show potential for differential clinical efficacy.
- Significant pre-clinical and clinical progress has been made in developing these compounds.
Conclusions:
- Novel microtubule-stabilizing natural products represent a promising avenue for cancer therapy.
- Understanding mechanistic nuances is key to optimizing their clinical application.
- Continued research and development are crucial for translating these findings into effective treatments.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Microtubule Formation
Microtubule Instability
Microtubule Instability

